Table 3 Oncological outcomes according to patient positioning
Oncological outcomes | PJ-APR | LT-APR | P value |
|---|---|---|---|
Survival | 59.5% (44/74) | 54.1% (20/37) | 0.593 |
Disease-free survival | 52.7% (39/74) | 51.4% (19/37) | 0.325 |
Local recurrence | 17.6% (13/74) | 18.9% (7/37) | 0.995 |
Distant metastasis | 23.0% (17/74) | 24.3% (9/37) | 0.811 |
5-year survival | 50.0% (16/32) | 42.9% (12/28) | 0.821 |
5-year disease-free survival | 46.9% (15/32) | 42.9% (12/28) | 0.638 |
5-year local recurrence | 9.4% (3/32) | 21.4% (6/28) | 0.173 |
5-year distant metastasis | 21.9% (7/32) | 28.6% (8/28) | 0.382 |